Labshake search
Citations for R&D Systems :
601 - 650 of 10000+ citations for 6H Dibenzo b d pyran 3 pentanaminium 6a 7 10 10a tetrahydro 1 hydroxy N N N 6 6 9 hexamethyl 6aR trans 9CI since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Cell Biology 2023Quote: ... 10 nM SB202190 (R&D Systems), 10 nM gastrin (R&D Systems) ...
-
bioRxiv - Systems Biology 2023Quote: ... and IL-10 (R&D Systems) at the noted time points ...
-
bioRxiv - Immunology 2024Quote: ... plus 10% FBS (R&D Systems), 1X GlutaMAX (Gibco) ...
-
bioRxiv - Cell Biology 2024Quote: ... AZ3146 (R&D Systems #3994/10) was used at 2μM ...
-
bioRxiv - Cell Biology 2021Quote: ... and 5 ng/mL TGF-β (R&D Systems, cat# 240-B-002). To test the effect of FYN depletion on collagen deposition ...
-
bioRxiv - Microbiology 2021Quote: ... 20μg of Anti IL28A/B (Clone 244716, MAB17892, R&D Systems, Minneapolis, MN) was infected intraperitoneally one day prior and each day following infection for the duration.
-
bioRxiv - Cancer Biology 2019Quote: ... Cells were treated with 10ng/mL TGFB1 (R&D Systems, #240-B-010), 30ng/mL EGF (Invitrogen ...
-
bioRxiv - Molecular Biology 2022Quote: ... and buffered with 1X E3 Ligase Reaction Buffer (R&D systems, B-71). Substrates and Z-VAD-FMK (UBPBio ...
-
bioRxiv - Cell Biology 2022Quote: ... cells were stimulated with rhTGF-β1 (2ng/mL; R&D Systems; 240-B) for 24 hours ...
-
bioRxiv - Cancer Biology 2022Quote: ... bioreactor media were either left untreated or supplemented with anti– Siglec-9 antibody (5 μg mL-1; clone 191240, #MAB1139-500, R&D systems, USA). On day 5 ...
-
bioRxiv - Cancer Biology 2021Quote: ... Negative control cells were produced by treatment with 10 μM Z-DEVD-FMK caspase-3 inhibitor (R&D systems). 200μl of cell suspension from each cell line including the negative control group was transferred into a flow cytometry tube before being treated with 2.5μl of 0.2mM NucViewTM 488 caspase-3 substrate (fluorogenic DNA dye and DEVD moiety substrate for caspase-3 ...
-
bioRxiv - Immunology 2020Quote: ... the media were refreshed and supplemented with 5 ng/mL IL-7 or 5 ng/mL IL-7 and 4 ng/ml IL-2 (R&D Systems), respectively ...
-
bioRxiv - Immunology 2022Quote: ... in the presence of IL-2 (10 ng ml−1, R&D Systems), anti-IL-10 (50 μg ml−1 ...
-
bioRxiv - Bioengineering 2020Quote: ... and 10 ng mL−1 IFN-γ (R&D Systems # 485-MI-100) was added ...
-
bioRxiv - Cancer Biology 2023Quote: ... and 10 ng/ml Nrg1 (HRG-beta-1 EGF domain) (R&D Systems) on poly-L-lysine (50 μg/ml ...
-
bioRxiv - Bioengineering 2023Quote: ... 1x Penn/Strep and 10 ng ml-1 activin (R&D Systems, 338AC010CF). On Day 7 media was changed to Advanced RPMI 1640 Medium ...
-
bioRxiv - Cancer Biology 2021Quote: ... and stained with the different cell surface antibodies (1:10 anti-CD112-PE [clone R2.525, BD Biosciences], 1:10 anti-CD155-PE [clone 300907, R&D Systems] ...
-
bioRxiv - Microbiology 2021Quote: ... were cultured for 7 days in RPMI supplemented with 5% decomplemented autologous human blood plasma and 10 ng/mL M-CSF (R&D system, #216-MC) to obtain MDMs ...
-
bioRxiv - Microbiology 2021Quote: ... and IGFBP-3 DuoSet ELISA kit (R&D Systems), respectively ...
-
bioRxiv - Developmental Biology 2020Quote: ... Rabbit α-Active Caspase-3 (R&D Systems, #AF835), Mouse α-PAX7 (DSHB) ...
-
bioRxiv - Developmental Biology 2020Quote: ... supplemented with BMP4 (3 ng/ml, R&D Systems) and Thiazovivin (2 μM ...
-
bioRxiv - Synthetic Biology 2021Quote: ... and 3 μM GSK3 inhibitor (R&D Systems, CHIR99021). mESC medium was made from Knockout DMEM (Gibco 10829018) ...
-
bioRxiv - Immunology 2020Quote: ... LAG-3 (Polyclonal, R&D Systems, Minneapolis, MN, USA), CD123 (clone 7G3) ...
-
bioRxiv - Bioengineering 2021Quote: ... 20ng/mL IL-3 (R&D Systems 203-IL), 20 ng/mL G-CSF (R&D Systems 214-CS) ...
-
bioRxiv - Bioengineering 2021Quote: ... 0.01µg/mL IL-3 (R&D Systems, 203-IL) and 0.005µg/mL TNFα (R&D Systems ...
-
bioRxiv - Cell Biology 2021Quote: ... with 20 ng/ml rmIL-3 (R&D Systems), 50 ng/ml Flt3-Ligand (R&D Systems ...
-
bioRxiv - Genetics 2019Quote: ... and 3 μM GSK3 inhibitor (R&D Systems, CHIR99021). mESC medium was made from Knockout DMEM (Gibco 10829018) ...
-
bioRxiv - Cancer Biology 2020Quote: ... anti-cleaved caspase 3 were from R&D Systems.
-
bioRxiv - Neuroscience 2023Quote: ... 10ng/mL NT-3 (R&D Systems 267-N3), 100 ng/mL IGF (R&D Systems ...
-
bioRxiv - Neuroscience 2023Quote: ... 10ng/mL NT-3 (R&D Systems 267-N3), 100 ng/mL IGF (R&D Systems ...
-
bioRxiv - Developmental Biology 2022Quote: ... 3 ng/ml rhBMP4 (R&D Systems, #314-BP), and 3 ng/ml rmWNT3a (R&D Systems ...
-
bioRxiv - Bioengineering 2023Quote: ... 8 μM GSK-3 inhibitor CHIR99021 (R&D Systems), 200 ng/ml fibroblast growth factor 9 (FGF9 ...
-
bioRxiv - Neuroscience 2023Quote: ... and 25 ng/ml rhIL-3 (R&D Systems). Macrophage precursor cells could be routinely harvested from dishes containing EBs every 6/7 days for up to 3/4 months ...
-
bioRxiv - Immunology 2024Quote: ... anti-LAG-3 (polyclonal goat IgG, R&D Systems), anti-PD-1 (cloneEH12.1 ...
-
bioRxiv - Cell Biology 2020Quote: Supernatant of confluent pulmonary endothelial cells were analyzed for TNF-α and IL-6 by using a mouse-specific ELISA from R&D Systems (Minneapolis, MN, USA) according to manufacturer’s protocol with the help of an Infinite M200 PRO plate reader (TECAN Instruments ...
-
bioRxiv - Bioengineering 2023Quote: The conditioned media from treated RAW264.7s was used to quantify levels of multiple secreted cytokines/chemokines using their respective ELISA kits including IL-6 (DY406; R&D Systems Incorporated, Minneapolis, MN, USA), TNF-⍰ (DY410 ...
-
bioRxiv - Cell Biology 2024Quote: ... TNF-α and IL-6 release was measured using DuoSet ELISA kits according to the manufacturer’s instructions (R&D Systems: DY417-05; DY410-05; DY406-05).
-
bioRxiv - Cell Biology 2021Quote: ... HTM cells were cultured in serum-free DMEM with 1% PSG and subjected to the different treatments for 3 d: TGFβ2 (2.5 ng/ml; R&D Systems, Minneapolis, MN, USA), the ERK inhibitor U0126 (10 μM ...
-
bioRxiv - Cancer Biology 2020Quote: ... were added to devices with THP-1 M1 macrophages while matrix metalloproteinase 7 (MMP7, clone 111433 at 1 μg/ml) and ANGPT2 (clone 85816 at 1 μg/ml) (all from R&D systems, Minneapolis, MN) neutralizing antibodies were added to devices with THP-1 M2 macrophages ...
-
bioRxiv - Cell Biology 2021Quote: ... 10 ng/mL recombinant human insulin-like growth factor 1 (IGF-1) (R&D Systems, USA), and 10 μM SB431542 (Tocris ...
-
bioRxiv - Cell Biology 2022Quote: ... DPP4 (IF/FACS 1:100, #HBB3/775/42, DSHB; EM 1:10, #AF1180, R&D Systems), E-Cadherin (IF 1:200 ...
-
bioRxiv - Biochemistry 2022Quote: ... or 1:1000 anti-Human/Mouse/Rat PRL-3 Antibody (R&D Systems, MAB3219, Lot. WXH0419091). Following three washes with 0.1% TBST ...
-
bioRxiv - Developmental Biology 2022Quote: ... Mesoderm lineage explants were generated using recombinant BMP4/7 heterodimer protein (R&D Systems) at a final concentration of 20g/mL in 1xMMR supplemented with 0.1% BSA ...
-
bioRxiv - Immunology 2019Quote: ... 5 ng/ml IL-7 and 5 ng/ml IL-15 (R&D Systems).
-
bioRxiv - Bioengineering 2020Quote: ... medium was switched to STEMdiff APEL medium supplemented with 200 ng/μl FGF-9 (R&D Systems) and 1 μg/ml heparin (Sigma-Aldrich) ...
-
bioRxiv - Immunology 2023Quote: ... lactoferrin and MMP-9 were detected in undiluted supernatant using ELISA kits (abcam and R&D systems).
-
bioRxiv - Immunology 2019Quote: ... We established in vitro quantification of granzyme B (antibody sets from R&D Systems) and perforin (antibody sets from MABTECH) ...
-
bioRxiv - Cancer Biology 2021Quote: ... Luciferase activity was confirmed using recombinant human TGFβ (R&D Systems, #240-B-010) treatment.
-
bioRxiv - Immunology 2022Quote: ... SARS-CoV-2 B.1.1.529 S GCN4-IZ-2P (11061-CV, R&D Systems), MERS-CoV S GCN4-IZ-2P (R&D Systems) ...
-
bioRxiv - Cancer Biology 2023Quote: ... and granzyme B DuoSet ELISA kits were purchased from R&D Systems (Minneapolis, MN). OVA 257-264 (SIINFEKL peptides) ...